Archived: Previous Version
Archived: Pancreatic Cancer: Screening
Original Release Date: February 2004
This version of this topic is currently archived and inactive. It should be used for historical purposes only.
Archived: Recommendation Summary
The USPSTF recommends against routine screening for pancreatic cancer in asymptomatic adults using abdominal palpation, ultrasonography, or serologic markers.
Rationale: The USPSTF found no evidence that screening for pancreatic cancer is effective in reducing mortality. There is a potential for significant harm due to the very low prevalence of pancreatic cancer, limited accuracy of available screening tests, the invasive nature of diagnostic tests, and the poor outcomes of treatment. As a result, the USPSTF concluded that the harms of screening for pancreatic cancer exceed any potential benefits.
Internet Citation: Final Update Summary: Pancreatic Cancer: Screening. U.S. Preventive Services Task Force. August 2019.